Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
262studies shown
Showing 85-96 of 262
Other study type icon
CompletedNCT06661616

Cognitive Effects Associated With Hippocampal Neurogenesis Induced by ECT in the Treatment of Depression

This summary needs review. Please check the official study record and contact the research team for details.

In France
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
France
Sponsor
Centre Hospitalier St Anne
Condition
Depression, Bipolarity
Drug study icon
CompletedEUCTR 2008-001829-33

Duloxetine Versus Placebo in the Long-Term Treatment of Patients with Late-Life Major Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.
Countries
France
Sponsor
Eli Lilly and Company
Condition
Depression
Drug study icon
CompletedNCT02493868

Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02422186

Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression

This study is completed in the United States, in France, in the United Kingdom, .... It is testing efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant for treatment-resistant depression.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 65 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedEUCTR 2015-005282-22

A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Adaptive Dose-Finding Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
France, Bulgaria, Finland, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Drug study icon
CompletedEUCTR 2022-000461-41

A Randomized, Double-blind, Multicenter, Parallel-Group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
France, Bulgaria, Czechia, ...
Sponsor
Janssen-Cilag International NV
Condition
Depression
Biological study icon
Recruitment unclearEUCTR 2019-001989-15

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Extension to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study is directly about Depression.

DepressionBiological
Countries
France, Czechia, Finland, ...
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.